Degenerate T-cell recognition of peptides on MHC molecules creates large holes in the T-cell repertoire

PLoS Computational Biology

Volumn 8, Issue 3, 2012, Pages

  Calis, Jorg J A ^a   de Boer, Rob J ^a   Keşmir, Can ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES; CYTOLOGY; MOLECULES; T-CELLS;

CELL-BE; CELL/B.E; CELL/BE; CELLULARS; HOST CELLS; SELF TOLERANCE; SELF-SIMILAR; T CELL RECOGNITION; T CELLS RECEPTORS;

PEPTIDES;

EPITOPE; HLA ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEOME; T LYMPHOCYTE RECEPTOR;

ARTICLE; AUTOIMMUNITY; BINDING AFFINITY; BINDING SITE; CELL DEGENERATION; CELLULAR IMMUNITY; COMPLEX FORMATION; CONTROLLED STUDY; CROSS REACTION; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOGENETICS; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; PREDICTION; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEOMICS; RISK ASSESSMENT; RISK FACTOR; T LYMPHOCYTE;

BACTERIA (MICROORGANISMS);

EID: 84861173090     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1002412     Document Type: Article

References (57)

1. Calis JJA, Sanchez-Perez GF, Kesmir C, (2010) MHC class I molecules exploit the low G+C content of pathogen genomes for enhanced presentation. Eur J Immunol 40: 2699-2709.
2. Howson JMM, Walker NM, Clayton D, Todd JA, Consortium TDG, (2009) Confirmation of HLA class II independent type 1 diabetes associations in the major histocompatibility complex including HLA-B and HLA-A. Diabetes Obes Metab 11 (Suppl 1): 31-45.
3. Pociot F, McDermott MF, (2002) Genetics of type 1 diabetes mellitus. Genes Immun 3: 235-249.
4. Toma A, Haddouk S, Briand JP, Camoin L, Gahery H, et al. (2005) Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients. Proc Natl Acad Sci U S A 102: 10581-10586.
5. Brynedal B, Duvefelt K, Jonasdottir G, Roos IM, Akesson E, et al. (2007) HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis. PLoS ONE 2: e664.
6. McDole J, Johnson AJ, Pirko I, (2006) The role of CD8+ T-cells in lesion formation and axonal dysfunction in multiple sclerosis. Neurol Res 28: 256-261.
7. Huseby ES, White J, Crawford F, Vass T, Becker D, et al. (2005) How the T cell repertoire becomes peptide and MHC specific. Cell 122: 247-260.
8. Rolland M, Nickle DC, Deng W, Frahm N, Brander C, et al. (2007) Recognition of HIV-1 peptides by host CTL is related to HIV-1 similarity to human proteins. PLoS ONE 2: e823.
9. Frankild S, De Boer RJ, Lund O, Nielsen M, Kesmir C, (2008) Amino acid similarity accounts for T cell cross-reactivity and for "holes" in the T cell repertoire. PLoS ONE 3: e1831.
10. Assarsson E, Sidney J, Oseroff C, Pasquetto V, Bui HH, et al. (2007) A quantitative analysis of the variables affecting the repertoire of T cell specificities recognized after vaccinia virus infection. J Immunol 178: 7890-7901.
11. Woelfl M, Rutebemberwa A, Mosbruger T, Mao Q, mei Li H, et al. (2008) Hepatitis C virus immune escape via exploitation of a hole in the T cell repertoire. J Immunol 181: 6435-6446.
12. Burroughs NJ, De Boer RJ, Kesmir C, (2004) Discriminating self from nonself with short peptides from large proteomes. Immunogenetics 56: 311-320.
13. Welsh RM, Che JW, Brehm MA, Selin LK, (2010) Heterologous immunity between viruses. Immunol Rev 235: 244-266.
14. Tynan FE, Elhassen D, Purcell AW, Burrows JM, Borg NA, et al. (2005) The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation. J Exp Med 202: 1249-1260.
15. Hoof I, Perez CL, Buggert M, Gustafsson RKL, Nielsen M, et al. (2010) Interdisciplinary analysis of HIV-specific CD8+ T cell responses against variant epitopes reveals restricted TCR promiscuity. J Immunol 184: 5383-5391.
16. Hausmann S, Biddison WE, Smith KJ, Ding YH, Garboczi DN, et al. (1999) Peptide recognition by two HLA-A2/Tax11-19-specific T cell clones in relationship to their MHC/peptide/TCR crystal structures. J Immunol 162: 5389-5397.
17. Lee JK, Stewart-Jones G, Dong T, Harlos K, Gleria KD, et al. (2004) T cell cross-reactivity and conformational changes during TCR engagement. J Exp Med 200: 1455-1466.
18. Boggiano C, Moya R, Pinilla C, Bihl F, Brander C, et al. (2005) Discovery and characterization of highly immunogenic and broadly recognized mimics of the HIV-1 CTL epitope Gag77-85. Eur J Immunol 35: 1428-1437.
19. Wucherpfennig KW, Call MJ, Deng L, Mariuzza R, (2009) Structural alterations in peptide-MHC recognition by self-reactive T cell receptors. Curr Opin Immunol 21: 590-595.
20. Rudolph MG, Stanfield RL, Wilson IA, (2006) How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol 24: 419-466.
21. Cole DK, Edwards ESJ, Wynn KK, Clement M, Miles JJ, et al. (2010) Modification of MHC anchor residues generates heteroclitic peptides that alter TCR binding and T cell recognition. J Immunol 185: 2600-2610.
22. Kesmir C, Nussbaum AK, Schild H, Detours V, Brunak S, (2002) Prediction of proteasome cleavage motifs by neural networks. Protein Eng 15: 287-296.
23. Nielsen M, Lundegaard C, Lund O, Kesmir C, (2005) The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage. Immunogenetics 57: 33-41.
24. Peters B, Bui HH, Frankild S, Nielson M, Lundegaard C, et al. (2006) A community resource benchmarking predictions of peptide binding to MHC-I molecules. PLoS Comput Biol 2: e65.
25. Larsen MV, Lundegaard C, Lamberth K, Buus S, Lund O, et al. (2007) Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinformatics 8: 424.
26. Huang DW, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
27. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: P3.
28. Embley TM, Martin W, (2006) Eukaryotic evolution, changes and challenges. Nature 440: 623-630.
29. Bakker AB, van der Burg SH, Huijbens RJ, Drijfhout JW, Melief CJ, et al. (1997) Analogues of CTL epitopes with improved MHC class-I binding capacity elicit anti-melanoma CTL recognizing the wild-type epitope. Int J Cancer 70: 302-309.
30. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, et al. (2000) The Protein Data Bank. Nucleic Acids Res 28: 235-242.
31. Kim Y, Sidney J, Pinilla C, Sette A, Peters B, (2009) Derivation of an amino acid similarity matrix for peptide: MHC binding and its application as a Bayesian prior. BMC Bioinformatics 10: 394.
32. Ishizuka J, Grebe K, Shenderov E, Peters B, Chen Q, et al. (2009) Quantitating T cell crossreactivity for unrelated peptide antigens. J Immunol 183: 4337-4345.
33. Blattman JN, Antia R, Sourdive DJD, Wang X, Kaech SM, et al. (2002) Estimating the precursor frequency of naive antigen-specific CD8 T cells. J Exp Med 195: 657-664.
34. Hataye J, Moon JJ, Khoruts A, Reilly C, Jenkins MK, (2006) Naive and memory CD4+ T cell survival controlled by clonal abundance. Science 312: 114-116.
35. Kotturi MF, Scott I, Wolfe T, Peters B, Sidney J, et al. (2008) Naive precursor frequencies and MHC binding rather than the degree of epitope diversity shape CD8+ T cell immunodominance. J Immunol 181: 2124-2133.
36. Borghans JA, De Boer RJ, (1998) Crossreactivity of the T-cell receptor. Immunol Today 19: 428-429.
37. Perez CL, Larsen MV, Gustafsson R, Norstrom MM, Atlas A, et al. (2008) Broadly immunogenic HLA class I supertype-restricted elite CTL epitopes recognized in a diverse population infected with different HIV-1 subtypes. J Immunol 180: 5092-5100.
38. Vita R, Zarebski L, Greenbaum JA, Emami H, Hoof I, et al. (2010) The immune epitope database 2.0. Nucleic Acids Res 38: D854-D862.
39. Banwell B, Krupp L, Kennedy J, Tellier R, Tenembaum S, et al. (2007) Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol 6: 773-781.
40. Rioux JD, Goyette P, Vyse TJ, et al. IMAGEN (2009) Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases. Proc Natl Acad Sci U S A 106: 18680-18685.
41. Jeffery KJ, Siddiqui AA, Bunce M, Lloyd AL, Vine AM, et al. (2000) The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J Immunol 165: 7278-7284.
42. Rocha EPC, Danchin A, (2002) Base composition bias might result from competition for metabolic resources. Trends Genet 18: 291-294.
43. Gough SCL, Simmonds MJ, (2007) The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action. Curr Genomics 8: 453-465.
44. Buus S, Lauemoller SL, Worning P, Kesmir C, Frimurer T, et al. (2003) Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach. Tissue Antigens 62: 378-384.
45. Nielsen M, Lundegaard C, Worning P, Lauemoller SL, Lamberth K, et al. (2003) Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci 12: 1007-1017.
46. Hoof I, Peters B, Sidney J, Pedersen LE, Sette A, et al. (2009) NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics 61: 1-13.
47. Peters B, Tong W, Sidney J, Sette A, Weng Z, (2003) Examining the independent binding assumption for binding of peptide epitopes to MHC-I molecules. Bioinformatics 19: 1765-1772.
48. Karosiene E, Lundegaard C, Lund O, Nielsen M, (2011) NetMHCcons: a consensus method for the major histocompatibility complex class I predictions. Immunogenetics: Online First DOI:10.1007/s00251-011-0579-8.
49. Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, et al. (1996) Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384: 134-141.
50. Ding YH, Smith KJ, Garboczi DN, Utz U, Biddison WE, et al. (1998) Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids. Immunity 8: 403-411.
51. Buslepp J, Wang H, Biddison WE, Appella E, Collins EJ, (2003) A correlation between TCR Valpha docking on MHC and CD8 dependence: implications for T cell selection. Immunity 19: 595-606.
52. Kjer-Nielsen L, Clements CS, Purcell AW, Brooks AG, Whisstock JC, et al. (2003) A structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunity. Immunity 18: 53-64.
53. Hoare HL, Sullivan LC, Pietra G, Clements CS, Lee EJ, et al. (2006) Structural basis for a major histocompatibility complex class Ib-restricted T cell response. Nat Immunol 7: 256-264.
54. Dunn SM, Rizkallah PJ, Baston E, Mahon T, Cameron B, et al. (2006) Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without increasing apparent cross-reactivity. Protein Sci 15: 710-721.
55. Gras S, Saulquin X, Reiser JB, Debeaupuis E, Echasserieau K, et al. (2009) Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope. J Immunol 183: 430-437.
56. Macdonald WA, Chen Z, Gras S, Archbold JK, Tynan FE, et al. (2009) T cell allorecognition via molecular mimicry. Immunity 31: 897-908.
57. Miles JJ, Bulek AM, Cole DK, Gostick E, Schauenburg AJA, et al. (2010) Genetic and structural basis for selection of a ubiquitous T cell receptor deployed in Epstein-Barr virus infection. PLoS Pathog 6: e1001198.